NCT05717504Withdrawn
Sweet spoT for cArdiac Rhythm monitorinG After sTrokE
STARGATE (Sweet spoT for cArdiac Rhythm monitorinG After sTrokE) Pilot Trial: A Pilot-feasibility Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Reason given: Withdrawn before enrollment because new clinical evidence made the study question no longer relevant.
Brief summary (registry, in English)
The goal of this clinical trial is to compare the use of long-term vs. shorter-term heart monitoring to detect atrial fibrillation after stroke. Patients will be implanted with a loop recorder and will have study follow-up at 3-, 6- an 12-months after implantation. The investigators will evaluate 24 patients, between the 3 centers, in the same way the investigators plan to evaluate a larger number of participants (>1000) in a future study. This will allow us to learn if such a study is possible, identify potential implementation challenges, and develop strategies to overcome those difficulties.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 13 Jan 2023
- Start date
- Nov 2023
- Primary completion date
- Oct 2024
- Lead sponsor
- Luciano A. Sposato
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT05717504
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other indications (e.g., venous thromboembolism) or contraindications for OACs.
Other
- AF on 24-h inpatient or Holter monitoring
- Atrial or ventricular thrombus
- Other major-risk cardioembolic sources (e.g., mechanical valve)
Who the study is looking for
- Adult patients with cortical or subcortical, cryptogenic or non-cryptogenic acute ischemic stroke
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.